Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proprotein Convertase Subtilisin/Kexin Type 9
Chiara Macchi, Nicola Ferri, Cesare R. Sirtori, et al.
American Journal Of Pathology (2021) Vol. 191, Iss. 8, pp. 1385-1397
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
Maciej Banach, Paweł Burchardt, Krzysztof Chlebus, et al.
Archives of Medical Science (2021) Vol. 17, Iss. 6, pp. 1447-1547
Open Access | Times Cited: 132
PCSK9 Biology and Its Role in Atherothrombosis
Cristina Barale, Elena Melchionda, Alessandro Morotti, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5880-5880
Open Access | Times Cited: 126
PCSK9 inhibitors for secondary prevention in patients with cardiovascular diseases: a bayesian network meta-analysis
Xing Wang, Dingke Wen, Yuqi Chen, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 52
Inclisiran: A Review in Hypercholesterolemia
James E. Frampton
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 2, pp. 219-230
Closed Access | Times Cited: 31
Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection
Khursheed Muzammil, Mohammad Hosseini Hooshiar, Shirin Varmazyar, et al.
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Platelets as an inter‐player between hyperlipidaemia and atherosclerosis
Nailin Li
Journal of Internal Medicine (2024) Vol. 296, Iss. 1, pp. 39-52
Open Access | Times Cited: 11
A promising therapy for fatty liver disease: PCSK9 inhibitors
Lizhu Han, Liuyun Wu, Qinan Yin, et al.
Phytomedicine (2024) Vol. 128, pp. 155505-155505
Closed Access | Times Cited: 9
Dengue virus induces PCSK9 expression to alter antiviral responses and disease outcomes
Esther S. Gan, Hwee Cheng Tan, Duyen Huynh Thi Le, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5223-5234
Open Access | Times Cited: 56
The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer
Nabil G. Seidah
Journal of Lipid Research (2021) Vol. 62, pp. 100130-100130
Open Access | Times Cited: 53
PCSK9: A Multi-Faceted Protein That Is Involved in Cardiovascular Biology
Sai Sahana Sundararaman, Yvonne Döring, Emiel P. C. van der Vorst
Biomedicines (2021) Vol. 9, Iss. 7, pp. 793-793
Open Access | Times Cited: 50
Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment
Shakir Ahamad, Shahnawaz Ali Bhat
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 23, pp. 15513-15539
Closed Access | Times Cited: 37
Gene Therapy Targeting PCSK9
Julius L. Katzmann, Arjen J. Cupido, Ulrich Laufs
Metabolites (2022) Vol. 12, Iss. 1, pp. 70-70
Open Access | Times Cited: 31
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?
Stefano Carugo, Cesare R. Sirtori, Alberto Corsini, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 12, pp. 995-1004
Open Access | Times Cited: 31
Pollution from fine particulate matter and atherosclerosis: A narrative review
Chiara Macchi, Cesare R. Sirtori, Alberto Corsini, et al.
Environment International (2023) Vol. 175, pp. 107923-107923
Open Access | Times Cited: 22
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system
Andrew S. Bell, Josephin Wagner, Daniel B. Rosoff, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105155-105155
Closed Access | Times Cited: 20
PCSK9 Inhibition Reduces Depressive like Behavior in CUMS-Exposed Rats: Highlights on HMGB1/RAGE/TLR4 Pathway, NLRP3 Inflammasome Complex and IDO-1
Nevien Hendawy, Tala H. Salaheldin, Sally A. Abuelezz
Journal of Neuroimmune Pharmacology (2023) Vol. 18, Iss. 1-2, pp. 195-207
Open Access | Times Cited: 19
Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors
Antonio Gallo, Wilfried Le Goff, Raul D. Santos, et al.
European Journal of Clinical Investigation (2024)
Open Access | Times Cited: 7
Triglyceride-rich lipoprotein and LDL particle subfractions and their association with incident type 2 diabetes: the PREVEND study
Sara Sokooti, Jose L. Flores‐Guerrero, Hiddo J.L. Heerspink, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 39
Platelet-Derived PCSK9 Is Associated with LDL Metabolism and Modulates Atherothrombotic Mechanisms in Coronary Artery Disease
Álvaro Petersen-Uribe, Marcel Kremser, Anne‐Katrin Rohlfing, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11179-11179
Open Access | Times Cited: 39
Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Marica Meroni, Miriam Longo, Rosa Lombardi, et al.
Hepatology Communications (2021) Vol. 6, Iss. 3, pp. 535-549
Open Access | Times Cited: 37
PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection
Natalie Arnold, Wolfgang Köenig
Current Cardiology Reports (2022) Vol. 24, Iss. 11, pp. 1657-1667
Open Access | Times Cited: 28
Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With Obesity
Chiara Macchi, Maria Francesca Greco, Chiara Favero, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 23
Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer
Qi‐Chao Yang, Shuo Wang, Yuan‐Tong Liu, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106916-106916
Open Access | Times Cited: 14
Cholesterol metabolism: physiological versus pathological aspects in intracerebral hemorrhage
Ruoyu Huang, Qiuyu Pang, Lexin Zheng, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 4, pp. 1015-1030
Open Access | Times Cited: 5
Remnant cholesterol is more positively related to diabetes, prediabetes, and insulin resistance than conventional lipid parameters and lipid ratios: A multicenter, large sample survey
Binqi Li, Yang Liu, Xin Zhou, et al.
Journal of Diabetes (2024) Vol. 16, Iss. 8
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top